A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease (AMBAR)
This study is currently recruiting participants. (see Contacts and Locations)
Verified March 2014 by Grifols Biologicals Inc.
Instituto Grifols, S.A.
Grifols Biologicals Inc.
Information provided by (Responsible Party):
Grifols Biologicals Inc. ( Instituto Grifols, S.A. )
First received: March 16, 2012
Last updated: March 7, 2014
Last verified: March 2014
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is currently recruiting participants.|
|Estimated Study Completion Date:||December 2016|
|Estimated Primary Completion Date:||December 2016 (Final data collection date for primary outcome measure)|